Notice2023-11725

Agency Information Collection Activities; Submission for Office of Management and Budget (OMB) Review; Comment Request; Expenditures Incurred by Recipients of Biomedical Research and Development Awards From the National Institutes of Health (NIH)

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
June 2, 2023

Issuing agencies

Commerce DepartmentEconomic Analysis Bureau

Full Text

<html>
<head>
<title>Federal Register, Volume 88 Issue 106 (Friday, June 2, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 106 (Friday, June 2, 2023)]
[Notices]
[Pages 36274-36275]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-11725]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Bureau of Economic Analysis


Agency Information Collection Activities; Submission for Office 
of Management and Budget (OMB) Review; Comment Request; Expenditures 
Incurred by Recipients of Biomedical Research and Development Awards 
From the National Institutes of Health (NIH)

    The Department of Commerce will submit the following information 
collection request to the Office of Management and Budget (OMB) for 
review and clearance in accordance with the Paperwork Reduction Act of 
1995, on or after the date of publication of this notice. We invite the 
general public and other Federal agencies to comment on proposed and 
continuing information collections, which helps us assess the impact of 
our information collection requirements and minimize the public's 
reporting burden. Public comments were previously requested via the 
Federal Register on March 21, 2023 during a 60-day comment period. This 
notice allows for an additional 30 days for public comments.
    Agency: Bureau of Economic Analysis (BEA), Commerce.
    Title: Expenditures Incurred by Recipients of Biomedical Research 
and Development Awards from the National Institutes of Health (NIH).
    OMB Control Number: 0608-0069.
    Form Number(s): None.
    Type of Request: Regular submission, extension of a current 
information collection.
    Number of Respondents: 150.
    Average Hours per Response: 16 hours is the average but may vary 
among respondents because of differences in institution structure, 
size, and complexity.
    Burden Hours: 2,400 hours.
    Needs and Uses: The survey obtains the distribution of expenditures 
incurred by recipients of biomedical research awards from the NIH and 
will provide information on how the NIH award amounts are expended 
across several major categories. This information, along with wage and 
price data from other published sources, will be used to generate the 
Biomedical Research and Development Price Index (BRDPI). The BRDPI is 
an index of prices paid for the labor, supplies, equipment, and other 
inputs required to perform the biomedical research the NIH supports in 
its intramural laboratories and through its awards to extramural 
organizations. The BRDPI is a vital tool for planning the NIH research 
budget and analyzing future NIH programs. A survey of award recipients 
is currently the only means for updating the expenditure category 
weights that are used to prepare the BRDPI. BEA develops the index for 
NIH under a reimbursable interagency agreement.
    A survey questionnaire with a cover letter that includes a brief 
description of, and rationale for, the survey will be sent to potential 
respondents by August 2023, 2024, and 2025. A report of the 
respondent's expenditures of the NIH award amounts following the 
proposed format for expenditure categories attached to the survey's 
cover letter, will be requested to be returned no later than December 8 
of each survey year, which in most years will be approximately 120 days 
after mailing. Survey respondents will be selected based on award 
levels, which determine the weight of the respondent in the BRDPI. BEA 
proposes to survey 150 organizations that receive NIH biomedical 
research awards. This will include the top 100 organizations in total 
awards received; 40 additional organizations that are not primarily in 
the ``Research and Development (R&D) contracts'' category; and 10 
additional organizations that are primarily in the ``R&D contracts'' 
category. Based on awards data for Fiscal Year 2022 by type of 
organization, the top 100 organizations received $25.2 billion in 
awards (approximately 76 percent of total awards); the remaining 
awards-receiving organizations received $8.1 billion.
    Affected Public: Universities or other organizations that are NIH 
award recipients.
    Frequency: Annual.
    Respondent's Obligation: Voluntary.

[[Page 36275]]

    Legal Authority: 45 CFR 75.302, 75.308, 75.361, and 75.364; 15 
U.S.C. 1525; 42 U.S.C. 282.
    This information collection request may be viewed at 
<a href="http://www.reginfo.gov">www.reginfo.gov</a>. Follow the instructions to view the Department of 
Commerce collections currently under review by OMB.
    Written comments and recommendations for the proposed information 
collection should be submitted within 30 days of the publication of 
this notice on the following website <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. 
Find this particular information collection by selecting ``Currently 
under 30-day Review--Open for Public Comments'' or by using the search 
function and entering either the title of the collection or the OMB 
Control Number 0608-0069.

Sheleen Dumas,
Department PRA Clearance Officer, Office of the Under Secretary for 
Economic Affairs, Commerce Department.
[FR Doc. 2023-11725 Filed 6-1-23; 8:45 am]
BILLING CODE 3510-06-P


</pre></body>
</html>
Indexed from Federal Register on June 2, 2023.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.